Latest News On FDA

Latest KFF Health News Stories

Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval

KFF Health News Original

Florida sued the FDA over what it said was a “reckless delay” in approving its drug importation plan. Now, nearly a year after the FDA gave the state the green light, the program has yet to begin.

What To Know About RFK Jr.’s Stances on Key Health Issues and What He Could Do at HHS

KFF Health News Original

Robert F. Kennedy Jr., President-elect Donald Trump’s pick to lead the Department of Health and Human Services, is coming into the nomination process in an unusual position, with a long list of his own policy priorities separate from the president-elect’s, and a public promise by Trump to let him “go wild” on his ideas. Céline […]

Scientists Fear What’s Next for Public Health if RFK Jr. Is Allowed To ‘Go Wild’

KFF Health News Original

As federal health scientists await a potential takeover by RFK Jr. and other medical skeptics in the second Trump administration, some are preparing résumés or retirement papers.

Qué le depara a la salud pública si se confirma Robert F. Kennedy Jr. como secretario de Salud

KFF Health News Original

Científicos de las agencias federales de salud esperan la segunda administración de Donald Trump con incertidumbre y temor, preguntándose cómo el presidente electo conciliará filosofías radicalmente diferentes entre los líderes de su equipo.

What’s at Stake: A Pivotal Election for Six Big Health Issues

KFF Health News Original

Health care has ebbed and surged as an election issue throughout the presidential campaign. Here are the ways some of the most consequential changes in health policies could hinge on whether Vice President Kamala Harris or former President Donald Trump wins.

KFF Health News' 'What the Health?': Less Than Two Weeks To Go

Podcast

With Election Day rapidly approaching, abortion is gaining traction as a voting issue, according to public opinion polls. Meanwhile, states with abortion bans are reviving the lawsuit — dismissed by the Supreme Court on a technicality this year — that could roll back the availability of the abortion pill mifepristone. Sarah Karlin-Smith of the Pink Sheet, Rachel Cohrs Zhang of Stat, and Victoria Knight of Axios join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Tricia Neuman, senior vice president of KFF and executive director of its Program on Medicare Policy, about Medicare open enrollment and the changes to the federal program for 2025.

FDA’s Promised Guidance on Pulse Oximeters Unlikely To End Decades of Racial Bias

KFF Health News Original

For decades, the pulse oximeters used in hospitals, ambulances, and homes have underestimated the oxygen needs of darker-skinned patients. The FDA is preparing guidelines to fix that. But will the new rules go far enough?

Unpacking the FDA’s Non-Recall Recalls

KFF Health News Original

When the Agriculture Department posted a recall of chicken nuggets that might be contaminated, it directed consumers to return them or throw the stuff away. When the Consumer Product Safety Commission announced that poorly designed baby loungers could suffocate babies, it warned consumers to immediately stop using them. But when it comes to medical devices, […]

With TV Drug Ads, What You See Is Not Necessarily What You Get

KFF Health News Original

The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.

Inside Project 2025: Former Trump Official Outlines Hard Right Turn Against Abortion

KFF Health News Original

Former President Donald Trump has distanced himself from a Heritage Foundation document that outlines positions on abortion and a range of other social issues. But Democrats view it as a window into the far right’s to-do list and a clear opening for political attack.

The CDC’s Test for Bird Flu Works, but It Has Issues

KFF Health News Original

The Centers for Disease Control and Prevention promises better tests are being developed, but the episode points to vulnerabilities in the country’s defense against emerging outbreaks.

Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma’s Weight Loss Drugs

KFF Health News Original

Although Novo Nordisk and Lilly lump together the pharmacies that compound semaglutide and tirzepatide with internet cowboys selling fake drugs, there is a distinction. The FDA has offered Americans little clarity about the vast gray and black markets for the drugs.